Displaying 1–25 of 221 results for Paul Thomas, Managing Editor

Sort By Relevance Sort By Date
1 2 3 4 5 ...9

Soaring Innovation, Grounded Goals

(Article)

Readers recognize tools that break new ground but promise to improve efficiency

Pfizer Newbridge Powers Up

(Article)

Michael Donlon and Dermot Doran of Pfizer Newbridge discuss the challenges and success of the site’s YOU Have the Power project.

EMD Millipore: Giving and Receiving Single-Use Systems

(Article)

A talk with sustainability manager Johanna Jobin about the company's new product recycling initiative.

Interphex 2012: Foster Wheeler Biokinetics Keeps Its Eyes on Future Drug ...

(Multimedia)

At Interphex 2012, Daniel Lachapelle, managing director for Foster Wheeler Biokinetics, provides an update on his company's core competencies in engineering, design, construction, and validation of biopharmaceutical facilities. Speaking with Pharmaceutical Manufacturing's Senior Editor Paul ...

Pharma Sustainability Is on a Roll

(Article)

Drug industry environmental stewardship projects are becoming more sophisticated and challenging. Here are examples from AstraZeneca, Bayer, DSM, Pfizer, and EMD Millipore

Sartorius and G-Con: Bioprocess Cleanrooms Go Mobile

(Article)

A joint collaboration claims it has a “disruptive technology” that can be shipped anywhere, and used in any way. Does it raise the bar for future flexible facilities?

With a Full Range of Products, EMD Millipore Turns Its Attention to Solutions

(Article)

The company aims to leverage the expertise it has always had in-house, yet hadn’t fully capitalized on with the pharma industry, says VP Christophe Couturier.

PharmaView: Who Will Be Pharma's Kane Waselenchuk?

(Article)

As conventional ways of making drugs give way, we will seek out these people and value their brilliance.

Pharma Jobs Are (Still) Going to Carolina

(Article)

BioNetwork’s Doug Drabble says there are jobs throughout the state, though workers won't always relocate to take them.

Cleanroom Couture and Other Fashionable Products

(Article)

A look at what’s new for the cleanroom set.

Is It Time for Biopharma OpEx to Grow Up?

(Article)

New research indicates that biopharma manufacturers have a desire for operational excellence but are not using sophisticated methods that are commonplace in other industries.

Striving for a Better Prefilled Syringe

(Article)

West and Vetter look to meet the needs of parenteral manufacturers demanding new, safer syringe options.

PharmaView: Time Away from a Life in Big Pharma

(Article)

“It is worth having dreams,” and worth fulfilling them, says former Novartis employee Anna Kroczak.

Jobs and Salaries: Pharma's Professionals Piece Together the Future

(Article)

Our eighth annual Job Satisfaction and Salary Survey says the big picture is brighter, though not clearer.

Technology Roundup: Machine Vision Insight Aids Operational Oversight

(Article)

Pharmaceutical machine vision technologies are getting simpler and cheaper, and yet tackling more varied applications.

Pfizer: Moving from Centralized to Holistic Supply Chain Security

(Article)

When it comes to patient safety, says Brian Johnson, there should be no “competitive advantage.”

PharmaView: Coming to America: European Companies Buy In and Lease

(Article)

"OUS" companies are enjoying the U.S. market, and creating a few jobs along the way.

Modular Construction in Pharma: No Longer a Novelty

(Article)

Modularly constructed facilities are becoming less expensive, and more practical, for small and large drug manufacturers alike.

Biopharma’s Future Facilities: Smaller Footprints, Complexities, and Costs

(Article)

A talk with Hyde’s Peter Watler about trends shaping biopharma facilities today and tomorrow.

MedImmune in Frederick: Using Ordinary Tools in Extraordinary Ways

(Article)

MedImmune’s approach may help take the blame off automation for plant startup delays.

Solvent Recovery at Pfizer: A Continuous Solution for Small Waste Streams

(Article)

When equipment and processes challenge solvent recovery for small-volume streams, an atypical approach is needed, says Pfizer’s Frank Urbanski.

PharmaView: Are Unions (Love 'Em or Not) the Last Bastion for Pharma Job ...

(Article)

Communities can partner with manufacturers, but they can’t apply pressure.

RMM Roundup: A Focus on Fast

(Article)

Rapid microbiological methods continue to be developed in order to support or supplant compendial methods.

PharmaView: Sell No Harm

(Article)

Makers of drugs for lethal injection face pressure to spurn U.S. prisons.

Sort By Relevance Sort By Date
1 2 3 4 5 ...9